Matt Hogan served as Chief Financial Officer at DURECT Corporation, a specialty pharmaceutical and late-stage biopharmaceutical company.
Matt Hogan served as Chief Financial Officer at DURECT Corporation, a specialty pharmaceutical and late-stage biopharmaceutical company. DURECT is focused on drug delivery platforms and epigenetic therapies, with operations in South San Francisco, California.
Full founder directory · Investor directory · Company funding database · Fundraising library